Agenus Inc (AGEN)
10.67
-0.19
(-1.75%)
USD |
NASDAQ |
May 20, 09:46
Agenus Price: 10.67 for May 20, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 10.50 | 11.41 | 10.30 | 10.86 | 429741.0 |
May 16, 2024 | 10.82 | 11.00 | 10.05 | 10.50 | 405012.0 |
May 15, 2024 | 10.85 | 11.06 | 10.59 | 10.78 | 355595.0 |
May 14, 2024 | 11.01 | 11.42 | 10.61 | 10.70 | 399122.0 |
May 13, 2024 | 10.53 | 11.26 | 10.36 | 11.09 | 395205.0 |
May 10, 2024 | 12.06 | 12.06 | 10.16 | 10.49 | 831166.0 |
May 09, 2024 | 11.54 | 12.45 | 11.50 | 11.72 | 561109.0 |
May 08, 2024 | 12.06 | 12.16 | 10.95 | 11.47 | 717486.0 |
May 07, 2024 | 12.45 | 13.00 | 10.70 | 12.01 | 1.269M |
May 06, 2024 | 13.22 | 13.39 | 12.70 | 12.95 | 417963.0 |
May 03, 2024 | 12.75 | 13.58 | 12.55 | 13.07 | 648418.0 |
May 02, 2024 | 13.52 | 14.04 | 12.34 | 12.52 | 979018.0 |
May 01, 2024 | 11.80 | 13.67 | 11.76 | 13.26 | 933882.0 |
Apr 30, 2024 | 12.76 | 12.76 | 11.05 | 12.12 | 1.184M |
Apr 29, 2024 | 12.11 | 14.24 | 11.77 | 12.76 | 2.828M |
Apr 26, 2024 | 8.60 | 12.23 | 8.45 | 11.69 | 3.367M |
Apr 25, 2024 | 7.35 | 8.47 | 7.20 | 8.30 | 961370.0 |
Apr 24, 2024 | 6.84 | 7.74 | 6.31 | 7.42 | 1.274M |
Apr 23, 2024 | 5.76 | 7.51 | 5.70 | 6.46 | 1.689M |
Apr 22, 2024 | 5.40 | 5.85 | 4.91 | 5.77 | 900544.0 |
Apr 19, 2024 | 4.96 | 5.87 | 4.900 | 5.31 | 1.464M |
Apr 18, 2024 | 5.36 | 6.14 | 4.775 | 4.97 | 1.671M |
Apr 17, 2024 | 6.34 | 6.52 | 5.38 | 5.40 | 1.527M |
Apr 16, 2024 | 6.46 | 6.98 | 6.155 | 6.30 | 1.323M |
Apr 15, 2024 | 8.58 | 9.22 | 6.43 | 6.50 | 1.459M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.97
Minimum
Apr 18 2024
130.05
Maximum
Aug 30 2021
54.57
Average
52.77
Median
Jul 05 2019
Price Benchmarks
Ligand Pharmaceuticals Inc | 86.00 |
Protalix BioTherapeutics Inc | 1.14 |
InfuSystems Holdings Inc | 6.44 |
PAVmed Inc | 1.79 |
Allogene Therapeutics Inc | 2.71 |
Price Related Metrics
PS Ratio | 0.9369 |
Earnings Yield | -659.8% |
Market Cap | 224.06M |